ClinicalTrials.govpublic full text
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
esophageal squamous cell carcinoma, neoadjuvant chemoimmunotherapy, adjuvant therapy, neoadjuvant chemotherapy, neoadjuvant immunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 842052
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.